Background To explore long-term ramifications of agalsidase alfa about Fabry disease cardiomyopathy in adults. a decrease in remaining ventricular mass. Conclusions 10 Approximately?years of agalsidase alfa treatment seemed to possess beneficial results for controlling development and improving some symptoms of Fabry-associated cardiomyopathy. statistic ideals. Variations were considered significant if p – ideals were 0 statically.05.… Continue reading Background To explore long-term ramifications of agalsidase alfa about Fabry disease